Sepragen Corporation – company video
Mr. Vinit Saxena is the founder and CEO of Sepragen Corporation, a company specializing in providing innovative and award-winning bio-processing equipment and consumables for the production and purification of biological drugs, high-end nutritional and dairy ingredients and vaccines. Sepragen's patented technologies are used globally in producing 30 FDA approved drugs including 100s of millions of doses of two approved and well known Covid-19 vaccines. Sepragen’s customers are on 4 continents and include bio-pharma industry leaders such as Abbvie, Amgen, GSK, Octapharma, Novartis, Sanofi, Takeda, Serum Institute and Biocon as well several leading nutritional companies such as Arla, Bega, Carbery and Mead Johnson. Sepragen’s products enable high throughput purifications and rapid scale-up at lower costs. Mr. Saxena’s industry experience spans over thirty-five (35) years including senior roles in marketing and manufacturing at leading life science suppliers and CMOs. Mr. Saxena is a graduate of IIT Kanpur, India and has an MS in Chemical Engineering from Syracuse University and an MBA from U.C. Berkeley. He has authored over 15 patents and several publications in trade press and peer reviewed journals. He has been a featured presenter and chair at several industry conferences and panels. He is on the Scientific Advisory Board of The Keck Graduate Institute, Claremont, CA and served as adjunct faculty advisor to doctoral students. He is also the winner of several SBIR grants and the prestigious IR 100 award.
Renu Chabra is the COO of Sepragen. An engineer by training, she has 30+ years of industry experience in senior technical and executive roles in life science instrumentation, medical devices and A.I. at companies such as Varian, Quintus, Kinetech and Scanis. Renu has been at Sepragen for over 25 years and over that time has been the architect of developing Sepragen’s array of Chromatography portfolio of instruments including single-use and buffer blending systems and the innovative electronics and software that drives them. She is also the steward of Sepragen developing a company culture which is driven by people “keeping their word” and developing an extraordinarily cohesive, high-performing team of engineers and scientists that have consistently delivered world class, state-of -the-art products. In just 14 weeks her team delivered innovative large several 125 lpm Chromatography systems combined with buffer blending capabilities that enabled a client to scale up Covid vaccine scale from 40M doses/mo to 200M doses/mo during the height of the pandemic! Ms. Chabra’s has a B.S. from California State University at San Francisco. She is an inventor as well and has authored several patents.
Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.